Oscar Health
OSCROscar Health is a technology-driven healthcare company that provides health insurance plans primarily in the individual market through the Affordable Care Act (ACA) marketplaces.
Earnings
Next report
Nov 9, 2026 (In 4 weeks)Valuation & ratios
Competitors
By market cap
By revenue growth
Profile
Oscar Health is a technology-driven healthcare company that provides health insurance plans primarily in the individual market through the Affordable Care Act (ACA) marketplaces. The company leverages a proprietary, cloud-native technology platform to deliver a personalized member experience, improve clinical engagement, and drive operational efficiencies. Its core value proposition centers on simplifying the healthcare ecosystem for individuals, families, and employees through data-driven insights and digital-first care navigation.
A leading technology-enabled health insurer with a significant presence in the ACA individual market and a first-mover advantage in cloud-native insurance infrastructure.
FAQ
- What is Oscar Health's market cap?
- Oscar Health (OSCR) has a market capitalization of $10.2B and trades on NYSE.
- What is Oscar Health's revenue and profitability?
- Oscar Health generated $15.3B in trailing twelve-month revenue with net income of $550.7M, representing a net margin of 3.6%, with free cash flow of $5.9B. The latest reported period is Q2 2026.
- Who are Oscar Health's competitors?
- Oscar Health's key competitors include CVS Health, UnitedHealth Group, Elevance Health, and others. These companies compete in similar markets and product categories.
- Who does Oscar Health partner with?
- Oscar Health's notable partners include Amazon Web Services, Google, Cigna, and others.
- What subsidiaries does Oscar Health have?
- Oscar Health's subsidiaries include Lucie, Inc., IHC Specialty Benefits, Inc., Healthinsurance.org, LLC, and others.
- Where is Oscar Health headquartered?
- Oscar Health is headquartered in United States of America and employs approximately 2,400 people. It has been publicly traded since 2021.
